NCT06852534View on ClinicalTrials.gov

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Eye-tracking Follow-up Study)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

April 2, 2025

Study Completion Date

April 2, 2025

Conditions
Basic Science: Visual Attention in Healthy ParticipantsAttention
Interventions
OTHER

Stimulus properties: salience-defining feature

The feature used to define a salient location will be varied across trials (checkerboard contrast; motion direction; color hue)

OTHER

Stimulus properties: magnitude of salience

The magnitude of the salient location will be varied across trials independently from salience-defining feature (based on feature contrast)

Trial Locations (1)

93117

University of California, Santa Barbara, Santa Barbara

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of California, Santa Barbara

OTHER

NCT06852534 - Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Eye-tracking Follow-up Study) | Biotech Hunter | Biotech Hunter